Prescription drug · ANDA
Bupropion Hydrochloride NDC 42806-410
Bupropion hydrochloride 100 mg/1 · Tablet, Extended release · Oral · Epic Pharma LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42806-410-01 | 42806041001 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-410-01)Marketed from Dec 15, 2021 | |
| 42806-410-05 | 42806041005 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-410-05)Marketed from Dec 15, 2021 | |
| 42806-410-60 | 42806041060 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-410-60)Marketed from Dec 15, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Bupropion Hydrochloride
- Generic name (nonproprietary)
- bupropion hydrochloride
- Active ingredients
- Bupropion hydrochloride — 100 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Epic Pharma LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075932
- Marketing start
- Listing expires
- Other FDA classes
- Dopamine Uptake Inhibitors (Mechanism)Increased Dopamine Activity (Physiologic effect)Increased Norepinephrine Activity (Physiologic effect)Norepinephrine Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 42806-410_af1a3522-8180-4e3f-a2fc-c9fe143997a3SPL ID af1a3522-8180-4e3f-a2fc-c9fe143997a3SPL set ID 9fb44e96-6160-4a4a-90cb-91764c0dcd89RxCUI 993503, 993518, 993536UNII ZG7E5POY8O
- Pharmacologic class
- Aminoketone
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442806041001followed by a unit qualifier and the quantityPackage 42806-0410-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Bupropion hydrochloride extended-release tablets (SR) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies (14)]. The efficacy of bupropion hydrochloride extended-release tablets (SR) in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see Clinical Studies (14)]. Bupropion hydrochloride extended-release tabl…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 075932
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Bupropion Hydrochloride | Bupropion hydrochloride 150 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6353 |
| Bupropion Hydrochloride | Bupropion hydrochloride 200 mg/1 | Tablet, Extended releaseOral | Epic Pharma LLC | 42806-411 |
| Bupropion Hydrochloride | Bupropion hydrochloride 150 mg/1 | Tablet, Extended releaseOral | Epic Pharma LLC | 42806-415 |